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Background: Regional rates of hospitalization for ambulatory care sensitive conditions (ACSC) are used to compare
the availability and quality of ambulatory care but the risk adjustment for population health status is often minimal.
The objectives of the study was to examine the impact of more extensive risk adjustment on regional comparisons
and to investigate the relationship between various area-level factors and the properly adjusted rates.
Methods: Our study is an observational study based on routine data of 2 million anonymous insured in 26 Swiss
cantons followed over one or two years. A binomial negative regression was modeled with increasingly detailed
information on health status (age and gender only, inpatient diagnoses, outpatient conditions inferred from
dispensed drugs and frequency of physician visits). Hospitalizations for ACSC were identified from principal
diagnoses detecting 19 conditions, with an updated list of ICD-10 diagnostic codes. Co-morbidities and surgical
procedures were used as exclusion criteria to improve the specificity of the detection of potentially avoidable
hospitalizations. The impact of the adjustment approaches was measured by changes in the standardized ratios
calculated with and without other data besides age and gender.
Results: 25% of cases identified by inpatient main diagnoses were removed by applying exclusion criteria. Cantonal
ACSC hospitalizations rates varied from to 1.4 to 8.9 per 1,000 insured, per year. Morbidity inferred from diagnoses
and drugs dramatically increased the predictive performance, the greatest effect found for conditions linked to an
ACSC. More visits were associated with fewer PAH although very high users were at greater risk and subjects who
had not consulted at negligible risk. By maximizing health status adjustment, two thirds of the cantons changed
their adjusted ratio by more than 10 percent. Cantonal variations remained substantial but unexplained by supply
or demand.
Conclusion: Additional adjustment for health status is required when using ACSC to monitor ambulatory care.
Drug-inferred morbidities are a promising approach.
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One approach to measuring the quality and availability
of primary care is to examine hospital admission rates
for conditions that, if treated early and appropriately, are
manageable outside the hospital setting. These are
known as ambulatory care sensitive conditions (ACSC)
[1,2]. Avoiding such hospitalizations represents a sub-
stantial gain in terms of costs and patient suffering. Fur-
thermore inpatients’ medical data are available in most
countries.
ACSC are identified from the main diagnosis coding
of inpatient stays. Several ACSC lists with their asso-
ciated disease codes (International Classification of
Diseases, 9th Revision, Clinical Modification, ICD-9-CM,
or International Classification of Diseases 10th Revision,
ICD-10) are available [3,4]. The assumption underlying
this concept is that timely access to effective primary care
should prevent the progression of the condition and thus
the need for hospitalization. Depending on the condition,
primary care can consist of primary prevention (e.g. for in-
fluenza); the early treatment of acute conditions (e.g. for
community-acquired bacterial pneumonia, urinary tract
infections and gastroenteritis); or the management of
chronic diseases (e.g. asthma, congestive heart failure and
diabetes).
Potentially avoidable hospitalization (PAH) rates due
to ACSC have been found to vary widely across geo-
graphical areas and population groups, suggesting that
the quality and availability of ambulatory care may be a
contributory factor [5-8]. Most conditions generate at
least one admission per 10,000 residents, a number con-
sidered sufficient to warrant further investigation [9,10].
Globally, PAH conditions account for 8 to 12% of all
hospitalizations [9-11], one in five adult non-obstetric
Medicare stays, and one in ten among Medicaid benefi-
ciaries [12,13].
PAH have been extensively examined as an indicator
of primary care accessibility. In the USA, higher PAH
rates have been consistently associated with lower in-
come, African American ethnicity, and lack of insurance
coverage, suggesting disparities in primary care access
[9,14,15]. The relationship between socioeconomic dis-
advantage and PAH may also reflect differences in dis-
ease prevalence. In comparisons of PAH rates, most
studies adjusted only for age and gender [2,14,16]. Some
also adjusted for disease prevalence, though this was re-
stricted to a small number of conditions for which such
information was available [17-19]. Incorporating self-
reported health status and history of chronic conditions
significantly weakened the relationship between all so-
cioeconomic variables and PAH [20,21].
Recently, health plan organizations or large physicians’
groups have shown a greater interest in the use of PAH
indicators for performance profiling. This represents amajor challenge because, in the absence of a proper risk
adjustment for patient health status, health plans might
improve their performance simply by enrolling healthier
individuals. In a recent structured review on possible in-
dicator refinement, clinical experts cited diagnoses from
prior hospitalizations within the past year and informa-
tion derived from pharmaceutical data as important risk
adjustment covariates [22].
Other factors for which ambulatory care providers
should not be held accountable may also be at work.
Variations in PAH rates should not be the result of
either differing hospital admission practices or the pro-
pensity of the subject to seek medical care [15].
In Switzerland the fact that health insurance is compul-
sory reduces the problem of access to care. Switzerland
is also a highly decentralized federation, with each of
its 26 cantons having almost sole responsibility for the
organization and financing of their care services [23].
As a result, primary care is organized differently across
the country, making it possible to examine the influ-
ence of contrasting health care characteristics.
Linking databases of several large insurers’ claims and
hospitalization records enabled us to examine PAH by
using individual data on a nationally representative co-
hort of insured persons. Our study aimed to assess the
impact of various severity adjustment strategies on the
indicator variations by using increasingly detailed infor-
mation on health status (age and gender only, inpatient
diagnoses, outpatient conditions inferred from dispensed
drugs data and frequency of care use). We then investi-
gated the association between the properly adjusted indi-
cator and socioeconomic factors and/or care services
characteristics.
Methods
Studied population
Our study is an observational study based on routine
data from four Swiss health insurers for the years 2005
and 2006. Data were collected with the support of the
Swiss Federal Office of Public Health [24]. The studied
population included 2,022,019 individuals who were in-
sured with one of those Swiss health insurers in 2005.
They were followed from January 1 until December 31,
2005 (335,538), and until December 31, 2006 (1,686,481)
for those who did not change insurer during the obser-
vation period (in Switzerland changes are only permitted
at the end of the year). All their health service bills and
drugs claims were systematically collected and matched
against hospital medical records through an anonymous
linkage code established by the Swiss Federal Statistical
Office (SFSO) encryption process (only the sequential
number of the patient was supplied) [25]. Hospital data
supplied by the Federal Statistical Office (inpatient diag-
noses) are publicly available. Insurers’ data (dispensed
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and were supplied only for the research project supported
by the Federal Public Health Office, with the prerequisite
of using the anonymous linkage code procedure of the
Federal Statistical Office. All data were anonymous and
did not include any information which might identify the
individual (date of birth, ZIP code, etc.) [26].
Outcome
The outcome was the number of PAH occurring between
1 July 2005 and 31 December 2005/2006, with 182 and
547 days of follow-up respectively. An ACSC was retained
from the main inpatient diagnosis. Conditions were identi-
fied by ICD-10 codes listed by Purdy et al. and established
from an exhaustive literature review updated in 2007 [4].
A few additional codes were added for specific conditions
(e.g. gastroenteritis due to food poisoning and otitis
externa; see Additional file 1 for list). The following diag-
noses were removed from Purdy’s list (see Additional
file 1 for codes). It is probable that minor dental problems,
which rarely require hospitalisation, are linked to admis-
sion practices rather than the efficiency of primary care. A
few conditions did not fit into the clinical definition of
ACSC: oesophagitis and oesophageal reflux (perforated or
bleeding ulcer category): and aplastic or auto-immune an-
aemia (deficiency anaemia category). We also excluded
eclampsia (convulsions category) and late complications
of diabetes (which signal problems with the care provided
at a much earlier stage) because these could not be man-
aged by primary care during the observation period.
Cases with a comorbid condition requiring hospitalization
were also left out: newborns, deliveries, trauma and
life-threatening diseases (see Additional file 2), as were
cases involving therapeutic operations that required
hospitalization, insofar as they were not the consequence
of an ACSC. Consequently, the following operations asso-
ciated with specific ACS conditions were deemed not to
be exclusion criteria: operation on stomach, peritoneum
and oesophagus for bleeding ulcer; lower limb amputation
for gangrene; minor operation on uterus and operation on
vagina for pelvic inflammatory diseases; minor operation
on mouth and teeth for dental conditions. Diagnoses and
surgical SQLape® categories were used to identify these ex-
clusion conditions [27].
Predictors of PAH
All independent variables were measured between
January 1 and June 30 2005, which corresponds to the ob-
servation period prior to the cohort zero time (1 July 2005).
The characteristics of the insured were:
– their canton of residence (seven cantons that
accounted for less than 0.5% of the insured were
grouped with neighbouring cantons);– gender and age by decade;
– morbidities deduced from inpatient diagnoses (up to
10 ICD-10 codes) and outpatient dispensed drugs
(Anatomical Therapeutical Chemical, ATC codes)
according to the SQLape® grouper, which is suited to
the nomenclatures used in Switzerland (adaptation of
ICD-10 diagnostic codes and ICD-9-CM procedures
codes, as well as specific pharmaceutical codes).
Clinically related SQLape® categories with a similar
PAH risk were grouped (see Additional file 3 for a
description of these morbidity groups). Although
several chronic conditions have been consistently
associated with PAH risk [28,29], it is the number
of chronic conditions suffered by the patient that
dramatically increases their PAH risk [30]. A case mix
measure, therefore, should capture the cumulative
effect of multiple conditions. Because Charlson and
Elixhauser indices consider only a limited number of
chronic conditions [31], we systematically extended
the analysis to all groups of acute and chronic diseases
(Additional file 3). A morbidity group identified both
from inpatient and outpatient information was
considered only once. When a condition could be
classified into several categories related to the same
pathology, only the most severe was retained (severe
infection > complicated infection > other infection >
urinary infection; complicated diabetes > diabetes
without complications). Patients who could be
classified into more than half of the morbidity
categories related to an ACSC were allocated a
specific category, referred to as “ACSC related
multimorbidity” (see Table 1).
The intensity of care was measured by the number of
physician visits during the six-month observation period
(before July 2005), including ambulatory visits made by
hospital physicians. However, we excluded ambulatory
consultations with a radiologist and hospital visits in the
24 hours prior to hospitalization. The number of phys-
ician visits may depend on several factors, including dis-
ease severity, the propensity of the subject to seek care,
and the physicians’ behaviour.
Several cantons allow physicians to dispense drugs to
patients directly (self-dispensation). In such cases, infor-
mation on dispensed drugs was missing. To adjust for a
possible bias, we introduced an additional variable,
which took the value of 1 if self-dispensation repre-
sented more than 5% of drug costs.
To examine the influence of cantonal differences in
health care supply and demand, cantonal level variables
were obtained from the SFSO [32]. A higher number of
ambulatory care facilities, reflected in the annual costs
for ambulatory care services per inhabitant, were ex-
pected to be associated with lower PAH rates, whereas
Table 1 Part A. Multivariate analysis of PAH incidence rates using different risk adjustment models (N = 2,022,019)
Adjustment models
Age-sex Inpatient
morbidity
Outpatient
morbidity
Whole morbidity Number of medical
visits
Variables Number (%) IRR IRR IRR IRR 95% CI IRR 95% CI
Demographic
Men 0-10 96,229 (4.8) 2.53 2.54 2.80 2.82 2.52 3.16 5.28 4.70 5.93
Men 11-20 110,428 (5.5) 0.98ns 1.02ns 1.18 1.21 1.06 1.39 2.71 2.36 3.11
Men 21-30 125,720 (6.2) 0.98ns 1.00ns 1.18 1.19 1.04 1.36 2.48 2.17 2.84
Men 31-40 156,812 (7.8) 1.01ns 1.03ns 1.16 1.16 1.03 1.32 2.14 1.89 2.43
Men 41-50 164,037 (8.1) 1.30 1.29 1.39 1.37 1.22 1.53 2.08 1.85 2.33
Men 51-60 137,066 (6.8) 2.31 2.15 1.97 1.85 1.68 2.09 2.33 2.09 2.60
Men 61-70 101,636 (5.0) 4.08 3.48 2.66 2.42 2.17 2.69 2.60 2.34 2.89
Men 71-80 65,069 (3.2) 7.78 6.12 3.67 3.25 2.91 3.61 3.28 2.96 3.65
Men 81-90 32,187 (1.6) 12.95 9.80 5.26 4.67 4.16 5.24 4.55 4.08 5.08
Men 91-100 6,655 (0.3) 15.52 12.86 7.79 6.87 5.72 8.27 6.65 5.62 7.88
Women 0-10 92,082 (4.6) 2.03 2.00 2.34 2.32 2.06 2.61 5.05 4.47 5.70
Women 11-20 104,850 (5.2) 1.10ns 1.13ns 1.30 1.32 1.16 1.45 2.65 2.11 3.03
Women 21-30 123,566 (6.1) 1.26 1.27 1.32 1.34 1.18 1.52 1.44 1.27 1.63
Women 41-50 157,341 (7.8) 1.16 1.13 1.09ns 1.08 0.96 1.22 1.55 1.37 1.74
Women 51-60 134,850 (6.7) 1.68 1.59 1.35 1.19 1.16 1.45 1.87 1.67 2.09
Women 61-70 105,225 (5.2) 2.87 2.61 1.81 1.73 1.55 1.93 2.29 2.06 2.55
Women 71-80 81,157 (4.0) 5.01 4.28 2.36 2.24 2.00 2.50 2.74 2.47 3.05
Women 81-90 53,433 (2.6) 9.36 7.57 3.91 3.66 3.28 4.08 4.17 3.75 4.63
Women 91-100 15,375 (0.8) 9.39 8.08 4.86 4.54 3.93 5.26 5.12 4.45 5.88
ACSC related conditions
Bronchitis and asthma 17,302 (0.86) 3.05 3.65 3.07 2.88 3.27 2.12 2.01 2.23
Diabetes, complicated 2,627 (0.13) 1.61 - 1.19 0.99 1.42 1.03 .89 1.20
Diabetes, no complicated 14,714 (0.73) 1.14ns 1.89 1.75 1.62 1.90 1.33 1.24 1.42
Epilepsy 6,058 (0.30) 7.57 2.48 2.85 2.54 3.20 1.62 1.47 1.78
Female genital tract 20,589 (1.02) 1.50 1.41 1.24 1.13 1.36 0.70 0.65 0.77
Gastro-intestinal tract 34,765 (1.72) 2.33 1.41 1.37 1.30 1.46 1.06 1.01 1.11
Heart diseases 22,805 (1.13) 1.40 1.37 .99 .99 1.07 1.03 .97 1.09
HTA and other circulatory disorder 75,163 (3.72) 0.94ns 2.73 3.00 2.75 3.08 1.13 1.08 1.18
Infection, complicated 2,526 (0.12) 2.85 - 2.88 2.35 3.53 1.32 1.12 1.55
Infection, other 65,106 (3.22) 3.53 2.81 3.01 2.86 3.17 1.19 1.14 1.24
Infection, severe 1,699 (0.08) 3.47 - 3.85 3.14 4.71 1.91 1.63 2.24
Intestinal or urinary obstruction 3,640 (0.18) 0.97ns - .74 .60 .91 .52 .44 .63
Nutritional anemia 4,036 (0.20) 1.67 - 1.57 1.35 1.84 1.24 1.09 1.41
Severe lung disease 7,603 (0.38) 2.94 - 2.20 1.98 2.44 1.54 1.42 1.67
Urinary infection 4,347 (0.21) 1.57 - 1.87 1.48 2.38 1.07 .87 1.31
ACSC related multi-morbidity 2,281 (0.11) 17.07 15.13 29.39 25.33 34.10 5.12 4.55 5.76
Comorbidity categories
Cancer 7,944 (0.39) 0.83 0.94ns .70 .62 .78 .61 .55 .68
CNS diseases 3,014 (0.15) 1.22 - 1.03 .88 1.21 1.00 .88 1.14
Endocrine diseases 8,408 (0.42) 1.13ns 0.97ns 1.02 .92 1.13 .98 .90 1.06
Liver & biliary tract 6,272 (0.31) 1.12ns 1.04ns .94 .83 1.06 .87 .79 .96
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Table 1 Part A. Multivariate analysis of PAH incidence rates using different risk adjustment models (N = 2,022,019)
(Continued)
Mental disorders 51,605 (2.55) 1.51 1.52 1.48 1.40 1.57 1.05 1.01 1.10
Metabolic disorders 19,825 (0.98) 1.33 1.26 1.08 1.00 1.16 1.04 .98 1.10
Nephritis 6,841 (0.34) 1.22 - 1.05 0.94 1.16 1.16 1.06 1.26
Other lung disease 5,478 (0.27) 1.28 .76ns 1.06 0.95 1.19 1.12 1.03 1.23
Pain & chronic restriction of mobility 27,280 (1.35) 0.91ns 1.22 .93 .87 .99 .80 .76 .85
Systemic rheumatic diseases and transplantation 1,388 (0.07) 1.16ns 1.90 1.29 1.05 1.58 1.23 1.04 1.45
Skin diseases 35,802 (1.77) 1.26 1.45 1.32 1.24 1.40 .99 .95 1.04
Thrombosis 39,704 (1.96) 0.81 1.36 1.32 1.24 1.39 1.08 1.04 1.45
Trauma 9,074 (0.45) 0.62 - .53 .47 .60 .49 .45 .54
Physician self-dispensation - - 1.16 1.15 1.11 1.20 .92 .89 .95
2006 follow-up 1,686,481 (83.41) 2.02 2.16 1.74 1.80 1.64 1.97 .99 .90 1.08
Number of medical contacts See Figure 1
Measures of model fit
AIC 179,024 172,473 162,835 159,196 130,962
BIC 179,299 173,112 163,361 159,847 131,776
Pseudo R2 5.2 8.7 14.1 15.8 30.8
CI: confidence interval; IRR: incidence rate ratio; ns: not significant (p ≥ 0.05).
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with higher rates. Health care supply was measured by
the number of primary care independent office-based
general practitioners (generalists, internists, and paedia-
tricians), the number of independent office-based clinical
specialists, as well as the number of hospital beds and
pharmacists. All were expressed per 1,000 inhabitants.
The aim of using demand variables was to identify po-
tential variations in the propensity to use ambulatory
care services. A higher level of education (average num-
ber of years), higher annual income per capita, a higher
proportion of urban residency, and a higher proportion
of insured persons who use primary care providers as
gatekeepers might be variables associated with a greater
propensity to seek medical care earlier, and thus with
lower PAH rates.
Other variables had a possible link to poor health
(unemployment rate and low deductible with a ceiling
effect) or to reduced access to physicians (higher deduct-
ible with a floor effect).
Statistical analysis
The number of PAH observed per patient (count data)
was modeled by a binomial negative regression with the
number of follow-up days as exposure [33]. To remove
bias due to unmeasured characteristics linked to the fact
of changing insurer, a dummy variable was added in the
model (2006 follow-up: 1 = yes, 0 = no). The demo-
graphic model included only gender and age. The clin-
ical model accounted for morbidities in three ways:
outpatient conditions inferred from data on dispenseddrugs; inpatient conditions only; both conditions. All
morbidity categories were included as dummy variables,
and were retained if IRR differed significantly from 1.0
in at least one model. The full model included all avail-
able variables, including the number of physicians’ visits
with three dummy variables: “no visit” (1 if zero visit),
“20-29 visits” (1 if the number of visits is between 20
and 29) and “30 and more visits” (1 if there are at least
30 visits).
The Akaike information criterion (AIC) and the Bayesian
information criterion (BIC) were used to assess the pre-
dictive performance of the models and a χ2 was used to
test the goodness of fit [34]. The relative contribution
of the independent variables to predicting PAH was
gauged by comparing pseudo-R squared across the al-
ternative models.
While information on inpatient diagnoses are routinely
available from state agencies, data on drugs and ambula-
tory care use are generally available from payers’ organi-
zations alone. To assess how the omission of additional
information on health status affected the cantons’ profil-
ing based on adjusted PAH rates, we plotted the differ-
ence (y-axis) in the expected number of PAH by canton
under nested models, i.e. one based on complete infor-
mation and one with fewer predictors, against the aver-
age expected values (x-axis) [35]. This method is similar
to Bland and Altman plots for assessing agreement be-
tween two measurement methods, which have been
shown to be more appropriate than the often misleading
correlation coefficient [36]. The selection of risk adjus-
tors was determined by the availability of data reflecting
Table 2 Characteristics of the studied and Swiss
populations (2005–2006 average)
Characteristics Studied
population
Swiss
population
N = 2,022,019 N = 7,483,934
Age group in years, %
0–19 18.9 21.8
20–39 27.2 27.1
40–64 35.8 35.0
65–79 12.1 11.5
80 and over 6.0 4.6
Female, %
Deductible level, % 50.7 51.0
<300 14.6 14.1
300 45.0 45.1
>300 40.4 40.8
Death rate per 1,000 patients,
per year
7.7 8.1
Incidence rate of hospitalization
per 1,000 insured, per year
144 149
Incidence rate of PAH per
1,000 insured, per year
6.33 6.40
Sources.
Swiss Federal Statistical Office. Neuchâtel. Resident population by age from
1960 to 2009. [www.bfs.admin.ch/bfs/portal/fr/index/themen/01/02]
Hospital statistics 2005. Standard tables. Neuchâtel, SFSO, 2007.
Hospital statistics 2006. Standard tables. Neuchâtel, SFSO, 2008.
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SFSO; morbidity based on information about dispensed
drugs collected by insurers and billing organizations;
and complete data [37]. The expected number of PAH
per canton was computed by summing individual pre-
dicted counts. We determined the lower and upper
limit of y-random variation according to the method
adopted by Campbell et al. [38]. We also added two
guidelines to the graph, each of which indicated a 10%
relative increase or decrease in the standardized ratio
(see Additional file 4 for computation details). Cantons
lying above or below these lines were those whose stan-
dardized ratio increased (poorer performance) or de-
creased (better performance) by more than 10%.
The Spearman rank correlation coefficient (rs) was used
to test if there was an association between the cantonal
standardized ratio of PAH and each thematic group of
cantonal variables (for α = 0.05, significant if rs ≥0.472, 18
degrees of freedom). Estimates of the standardized ratio
for each canton were obtained by incorporating cantonal
effects as fixed in the final model.
All computations were performed using Stata version 11.
Results
The studied population of over two million people rep-
resented 27% of the general Swiss population in 2005
and 2006. The age, gender and deductible distribution,
as well as mortality and hospitalization rates were simi-
lar between the studied population and the Swiss popu-
lation (Table 2). Cantonal distribution differed markedly
between the two populations, reflecting the preferential
coverage that the four health insurance companies of-
fered in certain cantons.
There were 23,129 ACSC hospitalizations during the
follow-up period. Among them, 2,829 had a severe co-
morbidity justifying the hospitalization; 2,701 involved a
therapeutic operation requiring an inpatient stay; and
550 satisfied both of these exclusion criteria. There were
17,049 PAH during the follow-up period, corresponding
to 6.3 per 1,000 insured, per year. Observed PAH rates
per canton varied from 1.4 to 9.6 per 1,000 insured, per
year.
Table 1 shows the results of multivariate regressions.
The relationship between age and ACSC rates was
depicted by a J curve, with the lowest rate for category
31–40 among women and 11–40 among men, and a
sharp increase over that age. Across most age categories
the risk was higher among men than among women.
Even after adjusting for morbidity, the effect of demo-
graphic variables on PAH remained, albeit to a lesser ex-
tent. With the exception of hypertension, diabetes
without complications, and intestinal or urinary obstruc-
tion, all inpatient ACSC-related conditions increased
PAH rates. Risks associated with those conditions wererather similar when outpatient morbidity was added.
Most other SQLape categories that were not clinically
related to ACSC had no effect on PAH rates. Only a few
increased the risk significantly: mental disorders, throm-
bosis, skin diseases, systemic rheumatic diseases and
transplantation, metabolic disorders. Hospitalizations for
trauma presented a lower risk. The exclusion criteria ap-
plied to ACSC hospitalizations probably explains why
the PAH risk was lower for cancer, pain and chronic re-
striction of mobility, and intestinal/urinary obstruction.
Figure 1 shows that the frequency of contact with a
physician prior to follow-up had a strong influence on
the PAH risk. Subjects with no previous contact had a
very low risk (IRR versus one contact: 0.01). Among sub-
jects who had at least one medical consultation, the
PAH risk was lower for those who had made 19 or fewer
physician visits, but sharply increased once this fre-
quency rate was exceeded. The inclusion of the fre-
quency of contact in the model reduced the effect of
morbidity categories, and even “overcompensated” for
benign conditions like female genital tract disorders,
whose coefficient became negative.
The goodness of fit improved as more explanatory var-
iables related to patient health status were introduced.
The pseudo R2 was 5.2% with demographic variables,
8.7% with inpatient illnesses, 14.1% with outpatient
Figure 1 Potentially avoidable hospitalization and frequency of medical contact. Vertical lines: 95% CI.
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taken into account. Adding the frequency of physicians’
visits dramatically improved the pseudo R2 (30.8%),
mainly because of the considerably lower risk of PAH
among numerous individuals who did not consult a
doctor. AIC and BIC fell similarly. Differences between
observed and predicted probabilities under the full
model were negligible: Ҳ0
2 = 0.003, Ҳ1
2 = 4.71, Ҳ2
2 = 17.4,
Ҳ3
2 = 4.00, Ҳ4
2 = 0.27, indices referring to number of
predicted events. Observed and expected rates of two
events with the greatest differences in rates were 0.55
and 0.62 per 1,000 events.
Figure 2 shows the impact of different adjustment
strategies on the cantons’ performance profiling. We
considered that having either no contact or 20+ visits
reflected the severity of the condition. However, a fre-
quency rate of 19 or less, which was associated with a
lower PAH risk, might be attributable to prevailing med-
ical practices. Agreement between the demographic
model and the full model was acceptable for less than
one third of cantons.
Estimates of the standardized ratio per canton varied
from 0.50 to 1.34 (Additional file 5). Four cantons were
low outliers and six were high outliers.
We found no significant association between the can-
tonal standardized ratio and the characteristics of can-
tonal primary care supply or demand (Table 3).
Discussion
Although easily identified from the main diagnosis cod-
ing of inpatient stays, ACSC lists have varied substan-
tially from one study to the next, without a rigorous
argument to justify the inclusion and exclusion criteria
[4]. In our study, 25% of cases identified by inpatientmain diagnoses were removed by applying exclusion cri-
teria which detected surgery or severe comorbidities for
which hospitalization was appropriate.
Age and gender were insufficient to predict PAH risk.
Taking into account all possible clinical information is of
utmost importance for a fair comparison between care
providers groups or regions. Inpatient diagnoses, which
are available in most developed countries, should there-
fore be used. We recommend supplementing diagnosis-
based morbidities with drug-related information (often
available from insurers’ data) because of the substantial
change in expected rates. Inpatient diagnoses have a lim-
ited ability to describe the disease burden because only a
minority of patients is hospitalized and comorbidities
like hypertension are often not recorded in hospital data.
Studies have consistently found that combining phar-
macy and inpatient data is an effective way of predicting
care costs and utilization [39,40]. The full model provided
a relatively high pseudo R2 value (30.8%), but further re-
search is needed to assess predictive performances for
other settings in a cross-validation procedure (prediction
parameters computed on a random 50% development
sample, tested on the remaining 50% validation setting).
Most ACSC-related conditions, and the few other
chronic diseases associated with a PAH risk, were detect-
able from the data on dispensed drugs. Pharmacy-based
morbidity measures, however, have limitations. Distin-
guishing hypertension from heart disease is problematic
due to the fact that the same drug is used to treat both
conditions. Consequently, heart disease which showed a
higher risk in the inpatient model (accurate coding)
showed a lower risk in the drug-based morbidity models
(poor sensitivity). The opposite was observed for hyper-
tension (good sensitivity of drug screening). Similarly, in
Figure 2 Differences in expected values across the adjustment
models. Solid line: lower and upper limit of random variation.
Dotted line: 10% increase of decrease of expected values.
Table 3 Association between cantonal supply and
demand and PAH standardized ratio
Percentiles cut-off
25 50 75 Spearman
coefficienta
Sickness funds’ annual costs for
ambulatory care services, CHF
1.996 2.251 2.726 −0.270
Pro-pharmacy proportionb 0.082 0.268 0.414 0.048
Urban population proportionc 0.557 0.742 0.941 −0.081
Pharmacy density 0.136 0.190 0.362 −0.082
General practitioners’ density 0.583 0.620 0.681 0.162
Specialist practitioners’ density 0.999 1.172 1.608 −0.187
Hospital beds density 4.637 5.518 6.055 0.212
Annual cantonal income per
inhabitant, CHF
44.141 49.282 55.027 −0.067
Educational leveld 12.686 12.839 13.028 −0.169
Deductible (CHF) 648 693 736 −0.290
Gatekeeper proportion 0.031 0.073 0.147 0.299
Unemployment rates 30.70 32.90 41.81 −0.140
Rates are expressed per 1,000 inhabitants.
asignificant if ≥0.472 (18 degrees of freedom).
bproportion of medication costs dispensed by physicians.
cproportion of populations living in a town (>10,000 inhabitants).
daverage number of years in education.
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(only identified by diagnoses) appeared less risky than
complication-free diabetes (good sensitivity of drug screen-
ing). Another limitation is that drugs information allows
for the detection of only a handful of diseases [41].
Information on previous medical visits is also useful
for identifying the healthiest individuals (without any
visit) and the sickest (more than 19 visits within six
months). Among patients having at least one consult-
ation, PAH risk decreased with the frequency of consul-
tations, and then rose sharply when it exceeded 19. This
suggests that medical consultations in Switzerland have
a preventive effect on PAH. We did not include the cat-
egory “1 to 20 consultations” in the adjustment model
because it might reflect medical practices rather the se-
verity of the disease. In contrast, we retained the veryhigh use of care category, as this has been associated
with a high level of psychological distress, chronic condi-
tions and socioeconomic disadvantage rather than with
the practice behavior of physicians [5,42].
The 2006 follow-up dummy variable indicated that the
risk was twice as high for people insured by the same in-
surer in 2006 even after adjusting for whole morbidity.
However, the IRR was no more significant (0.90-1.08)
after adjusting for medical visits. The most probable ex-
planation was a higher propensity to switch to alterna-
tive health plans (restricted provider choice, level of
deductible, gate keeper) among the insured who were in
good health in 2005.
Risk adjustment for severity is a complex issue which
requires integrating electronic data recorded during clin-
ical care from multiple sources. These data may be diffi-
cult or expensive to obtain. Our pilot study showed the
feasibility of such integration. The adoption of these data
models is expected to increase rapidly in real-world set-
tings, spurred by the financial incentives of monitoring
the effectiveness of clinical care practices [43]. Some au-
thors [44], however, cautioned against over-adjusting for
patients characteristics, since primary care might also
have an impact on the prevalence and the severity of ill-
nesses through primary or secondary prevention, for
instance.
After proper adjustment, the rate ratios between the
lowest and highest outliers decreased from 6.7 (unadjusted
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ing that interregional differences were largely explained by
the health status of the insured. Nevertheless, this residual
variation merits further investigation. The lack of associ-
ation between supply/demand factors and PAH risk in
Switzerland might suggest that disparities in rates reflect
differences in individual physician practices rather than
varying levels of access to care. For example, physicians
who were more experienced, practiced according to clin-
ical guidelines or tended to use managed care plans, had
patients who experienced fewer admissions for COPD and
pneumonia [28].
Our findings contradict the correlation between PAH
and access to care (in particular the supply of primary care
physicians), which has been found consistently in studies
of the urban American population [17,45]. However,
Medicare beneficiaries living in regions with better access
to primary care did not experience lower rates [46]. Al-
though socioeconomic indices have been associated with
PAH rates in many USA studies [18,47,48], confounding
factors such as increased disease prevalence or severity
might contribute, at least partly, to this association. Such
associations are indeed weaker in settings where there is
universal access to care [49-51]. Nonetheless, our regional
analysis may miss relationships detected in more con-
trasted areas like small geographic areas or countries.
Variations between rates might also reflect factors
outside the control of ambulatory care, such as the ad-
mission policies of individual hospitals [52], coding
practices and unmeasured illness severity. Despite the
apparent face validity of ACSC admissions, there are
still many important issues from a clinical perspective
that remain unanswered, such as how preventable are
hospitalizations for a given condition [53].Conclusion
Addressing the issues of proper definition (list of exclu-
sion criteria), risk adjustment, and the data collection
burden would improve the usefulness of potentially
avoidable hospitalization rates for extended application
beyond a rough area level indicator of the whole ambu-
latory care system. PAH risk was strongly associated
with patients’ clinical characteristics regardless of age
and gender. A very high use of visits reflecting severe
conditions dramatically increased PAH risk.
Our study underscores the importance of adjusting
for many predisposing health conditions (both chronic
conditions drawn from previous studies as well as other
such conditions) when using PAH as an indicator of
quality. The use of ambulatory care had a preventive
effect on risk in Switzerland. We did not find any de-
mand or supply effect to explain the large variability in
PAH adjusted rates.Additional files
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